Tony Proctor Joins George Clinical as New Chief Financial Officer

Tony Proctor Takes on CFO Role at George Clinical

George Clinical, a prominent global clinical research organization based in Singapore, is excited to announce the recent appointment of Tony Proctor, CPA, as its new Chief Financial Officer (CFO). With more than 25 years of experience in financial leadership, Proctor is set to play a crucial role in enhancing the company’s operational excellence, strategic planning, and transformational growth.

Tony Proctor expressed his enthusiasm about joining the team, stating, "I am honored to join George Clinical and contribute to its mission of improving health outcomes through innovative clinical research. I look forward to partnering with this talented team to enhance our financial operations and support the overall vision of the company."

Before joining George Clinical, Proctor held significant financial leadership positions at notable organizations such as Lexitas, Parexel, and Syneos Health. He has been instrumental in architecting strategies for organic revenue acceleration, implementing best-in-class financial disciplines, and managing substantial organizational and systemic upgrades. His track record includes overseeing transformative merger and acquisition processes that drive measurable results, while specifically focusing on strategic growth initiatives and optimizing global financial operations.

Mary Gunn, CEO of George Clinical, remarked, "We are thrilled to welcome Tony to our team at this exciting stage of our growth. His extensive expertise in financial strategy and operational leadership will be pivotal in advancing our business and delivering exceptional value to clients worldwide."

Tony earned his MBA in finance from Campbell University and holds both a bachelor’s degree in accounting and a degree in business/finance from North Carolina State University. Additionally, he is a certified public accountant licensed in North Carolina.

In conclusion, as George Clinical continues to expand its global reach and enhance its clinical research capabilities, the addition of Tony Proctor as CFO symbolizes a strategic move towards fostering innovation and operational efficiency. With Proctor’s extensive background and proven leadership skills, the company is poised for an exciting future in improving health outcomes through comprehensive clinical trials.

For more information about George Clinical, visit www.georgeclinical.com.

Contact: Donna McDonnell, T +1 901 229 5345, [email protected]